Login

Luke H Chao, Ph.D. Assistant Professor of Genetics, HMS | The Molecules that Determine Cell Shape 00:00:00

Share On Facebook Share On Twitter

Changing our understanding of life through team science

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:10:00
Year-Round Tax Planning with Michael Pharris | Daniel Yerger - President of MY Wealth Planners
00:00:00
Joseph T. Breen, M.D. Otolaryngologist, Mayo Clinic
00:10:00
Investing arm within Clocktower Group, Clocktower Technology Ventures partners with phenomenal entrepreneurs|Steve Drobny,Founder and CEO,Clocktower Technology Ventures
00:10:00
Accumulating and Advancing Copper Assets: Insights from Leo Hathaway at One-to-One Mining Conference
00:10:00
Putting Clients First: Our Story and Commitment to Superior Financial Service | Chad Chase, Managing Principal, CGN Advisors, LLC.
00:10:00
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Mid-Market vs. Large-Cap Deals: Value Creation Challenges
00:10:00
Galena Mining: Advancing the Abra Base Metals Project in Western Australia
00:10:00
Innovative Medical Device Company Explores Global Market at ASX Small and Mid-Cap Conference | John Kelly , CEO, Atomo Diagnostics Ltd .
00:10:00
Proskauer is actively involved in improving the communities around the world|Lee Popkin,Partner,Proskauer Rose LLP
00:10:00
Erik Hirsch Discusses Investment Strategies on Schwab Network | Erik Hirsch, CEO, Hamilton Lane.

© 2017 - Neuhu+